Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,078,535 papers from all fields of science
Search
Sign In
Create Free Account
alglucerase
Known as:
alglucerase [Chemical/Ingredient]
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
6 relations
Drug Allergy
Enzymatic Activity [MoA]
GLUCOSYLCERAMIDASE
Liver diseases
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Alglucerase
C.E.M. Hollak
,
J. M. Aerts
,
M. H. J. Oers
BioDrugs
2012
Corpus ID: 71353623
SummaryGaucher disease is caused by a deficiency of glucocerebrosidase. It is the first lysosomal storage disorder for which…
Expand
2011
2011
[Therapeutic targets in Gaucher's disease].
P. Giraldo
,
M. Roca
Medicina clínica (Ed. impresa)
2011
Corpus ID: 24471447
2008
2008
[Enzyme replacement therapy for Gaucher's Disease].
Thomas Winckler
Pharmazie in unserer Zeit
2008
Corpus ID: 196776328
Rekombinant hergestellte Glucocerebrosidase (Imiglucerase, Cerezyme®) zur Therapie der lysosomalen Speicherkrankheit Morbus…
Expand
1998
1998
[Uveitis masquerade syndrome in Gaucher disease. Causal treatment by alglucerase substitution therapy].
K. Dann
,
C. Althaus
,
A. Kersten
,
S. vom Dahl
,
R. Sundmacher
Klinische Monatsblätter für Augenheilkunde
1998
Corpus ID: 21181794
BACKGROUND Gaucher's disease, a sphingolipidose transmitted by autosomal-recessive inheritance, is caused by a deficiency of the…
Expand
1997
1997
Should repeated partial splenectomy be attempted in patients with hematological diseases? Technical pitfalls and causes of failure in Gaucher's disease.
E. Freud
,
I. Cohen
,
M. Neuman
,
C. Mor
,
M. Zer
Journal of Pediatric Surgery
1997
Corpus ID: 28986951
1997
1997
[Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease].
J. Pérez-Calvo
,
P. Giraldo
,
M. Giralt
Sangre
1997
Corpus ID: 1594557
AIM To evaluate the efficacy of the treatment with alglucerase (Ceredase) in spanish patients diagnosed of Gaucher disease type 1…
Expand
1996
1996
Tissue distribution and half-lifes of intravenously administered alglucerase
Y. Xu
1996
Corpus ID: 57788006
1995
1995
A biochemical and immunocytochemical study on the targeting of alglucerase in murine liver
R. Willemsen
,
J. Tibbe
,
M. Kroos
,
B. M. Martin
,
A. Reuser
,
E. Ginns
The Histochemical Journal
1995
Corpus ID: 8855467
SummaryA current hypothesis is that functional glucocerebrosidase needs to be delivered to the lysosomes of tissue macrophages to…
Expand
1994
1994
HCG contamination of alglucerase: Clinical implications in low‐dose regimen
Yael Cohen
,
D. Elstein
,
A. Abrahamov
,
H. Hirsch
,
A. Zimran
American journal of hematology/oncology
1994
Corpus ID: 2768852
Alglucerase (Ceredase) is currently the treatment of choice for patients with symptomatic Gaucher disease. The contamination of…
Expand
Review
1992
Review
1992
Alglucerase. A review of its therapeutic use in Gaucher's disease.
R. Whittington
,
K. Goa
Drugs
1992
Corpus ID: 264001295
Alglucerase is a mannose-terminated form of human placental glucocerebrosidase, developed to treat patients with Gaucher's…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE